JP2022527825A5 - - Google Patents

Info

Publication number
JP2022527825A5
JP2022527825A5 JP2021559232A JP2021559232A JP2022527825A5 JP 2022527825 A5 JP2022527825 A5 JP 2022527825A5 JP 2021559232 A JP2021559232 A JP 2021559232A JP 2021559232 A JP2021559232 A JP 2021559232A JP 2022527825 A5 JP2022527825 A5 JP 2022527825A5
Authority
JP
Japan
Application number
JP2021559232A
Other languages
Japanese (ja)
Other versions
JP2022527825A (ja
JPWO2020205409A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/024866 external-priority patent/WO2020205409A1/en
Publication of JP2022527825A publication Critical patent/JP2022527825A/ja
Publication of JP2022527825A5 publication Critical patent/JP2022527825A5/ja
Publication of JPWO2020205409A5 publication Critical patent/JPWO2020205409A5/ja
Priority to JP2025010421A priority Critical patent/JP2025069232A/ja
Pending legal-status Critical Current

Links

JP2021559232A 2019-04-03 2020-03-26 薬物送達のためのイオン液体 Pending JP2022527825A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025010421A JP2025069232A (ja) 2019-04-03 2025-01-24 薬物送達のためのイオン液体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962828539P 2019-04-03 2019-04-03
US62/828,539 2019-04-03
PCT/US2020/024866 WO2020205409A1 (en) 2019-04-03 2020-03-26 Ionic liquids for drug delivery

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025010421A Division JP2025069232A (ja) 2019-04-03 2025-01-24 薬物送達のためのイオン液体

Publications (3)

Publication Number Publication Date
JP2022527825A JP2022527825A (ja) 2022-06-06
JP2022527825A5 true JP2022527825A5 (https=) 2023-03-27
JPWO2020205409A5 JPWO2020205409A5 (https=) 2023-03-27

Family

ID=70334107

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021559232A Pending JP2022527825A (ja) 2019-04-03 2020-03-26 薬物送達のためのイオン液体
JP2025010421A Pending JP2025069232A (ja) 2019-04-03 2025-01-24 薬物送達のためのイオン液体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025010421A Pending JP2025069232A (ja) 2019-04-03 2025-01-24 薬物送達のためのイオン液体

Country Status (6)

Country Link
US (1) US20220257767A1 (https=)
EP (1) EP3946261A1 (https=)
JP (2) JP2022527825A (https=)
KR (1) KR20220004066A (https=)
CN (1) CN113939273A (https=)
WO (1) WO2020205409A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021102084A1 (en) * 2019-11-22 2021-05-27 President And Fellows Of Harvard College Ionic liquids for drug delivery
AU2021336289A1 (en) * 2020-09-01 2023-05-04 I2O Therapeutics, Inc. Ionic liquid formulations for treating diabetes
CN112250588B (zh) * 2020-11-06 2023-03-31 哈尔滨工业大学(深圳) 一种左旋肉碱离子液体及其制备方法、应用
JP2024518169A (ja) * 2021-05-05 2024-04-25 アイ2オー セラピューティクス,インク. 炎症性疾患および自己免疫疾患を処置するためのイオン性液体製剤
US12005134B2 (en) 2021-06-30 2024-06-11 Abe Pharmaceutical Composition for stimulating facial hair growth and methods of manufacturing a composition for stimulating facial hair growth
CN118382429A (zh) 2021-10-08 2024-07-23 哈佛大学校长及研究员协会 用于药物递送的离子液体
EP4429704A4 (en) 2021-11-10 2025-11-05 I2O Therapeutics Inc IONIC LIQUID COMPOSITIONS
US20230165806A1 (en) * 2021-11-19 2023-06-01 Board Of Regents, The University Of Texas System Topical Therapy of Skin Fibrosis and Melanoma
CN114642733B (zh) * 2022-03-02 2023-08-22 中山大学 一种治疗雄激素源性脱发的组合物及其制备方法
US20260034075A1 (en) * 2022-08-01 2026-02-05 University Of Mississippi Choline carboxylic acid based ionic liquids as antimicrobial agents
WO2025147130A1 (ko) * 2024-01-03 2025-07-10 주식회사 바이온리퀴드 이온성 액체 또는 공융 용매를 이용한 신규 약물제형

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
US4737462A (en) 1982-10-19 1988-04-12 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
US4518584A (en) 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
IE58110B1 (en) 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US5073543A (en) 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
IT1229203B (it) 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
US5120548A (en) 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
US5733566A (en) 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5580578A (en) 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
AU701578B2 (en) 1992-08-21 1999-02-04 Vrije Universiteit Brussel Immunoglobulins devoid of light chains
US5591767A (en) 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
IT1270594B (it) 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
US6365185B1 (en) 1998-03-26 2002-04-02 University Of Cincinnati Self-destructing, controlled release peroral drug delivery system
US7943129B2 (en) 2000-05-26 2011-05-17 National Research Council Of Canada Single-domain brain-targeting antibody fragments derived from llama antibodies
US8541472B2 (en) * 2001-12-05 2013-09-24 Aseptica, Inc. Antiseptic compositions, methods and systems
MX2007010539A (es) * 2005-02-28 2007-10-17 Unilever Nv Composicion cosmetica mejorada.
CA2658673A1 (en) 2005-07-27 2008-02-01 Gerald J. Prud'homme Composition and method for prevention and treatment of type i and type ii diabetes
US20110092493A1 (en) * 2008-09-24 2011-04-21 Clark Levi Dose-controlled transdermal promethazine compositions and methods of use
EP2512518A1 (en) 2009-12-16 2012-10-24 Novo Nordisk A/S Glp-1 receptor agonist compounds with a modified n-terminus
CA2786953A1 (en) * 2010-01-12 2011-07-21 Florian Anders Foeger Pharmaceutical compositions for oral administration of insulin peptides
US10449254B2 (en) * 2013-11-03 2019-10-22 The Regents Of The University Of California Ionic liquids for transdermal drug delivery
KR20170052278A (ko) * 2015-11-04 2017-05-12 주식회사 엘지생활건강 바이오필름 제거용 구강 조성물
WO2017164627A2 (ko) * 2016-03-21 2017-09-28 주식회사 엘지생활건강 바이오필름 억제 또는 제거용 조성물
US10293080B2 (en) * 2016-10-05 2019-05-21 The Arizona Board Of Regents On Behalf Of Northern Arizona University Ionic liquids that sterilize and prevent biofilm formation in skin wound healing devices
US11213497B2 (en) * 2017-06-01 2022-01-04 Arizona Board Of Regents On Behalf Of Northern Arizona University Antibiofilm formulations
CN111918644A (zh) * 2017-11-17 2020-11-10 哈佛大学校长及研究员协会 用于内部递送的离子液体
EP3768240A4 (en) * 2018-03-19 2021-12-22 Cage Bio Inc. COMPOSITIONS OF IONIC LIQUID FOR THE TREATMENT OF ROSACEA
US11464738B2 (en) * 2018-05-11 2022-10-11 Wisconsin Alumni Research Foundation Ionic liquid-based nanoemulsion formulation for the efficient delivery of hydrophilic and hydrophobic therapeutic agents

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
JP2022527825A5 (https=)
BR112021014123A2 (https=)
JP2023503899A5 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
JP2023539699A5 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR202021024548U2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)